Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 283,570 |
|
|||||
| News | - | ||||||
| Day High | 35.20 | Low High |
|||||
| Day Low | 33.09 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Spyre Therapeutics Inc | SYRE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.94 | -2.72% | 33.67 | 17:51:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 34.89 | 33.09 | 35.20 | 33.67 | 34.61 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,031 | 283,570 | $ 34.18 | $ 9,691,933 | - | 10.42 - 47.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:38:17 | formt | 4,077 | $ 33.67 | USD |
Spyre Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.22B | 36.15M | - | 886k | -338.79M | -9.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Spyre Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SYRE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 34.45 | 37.50 | 33.05 | 34.99 | 374,918 | -0.78 | -2.26% |
| 1 Month | 38.64 | 40.49 | 31.755 | 35.52 | 325,441 | -4.97 | -12.86% |
| 3 Months | 41.41 | 47.97 | 31.27 | 37.02 | 386,206 | -7.74 | -18.69% |
| 6 Months | 20.14 | 47.97 | 14.22 | 31.74 | 387,840 | 13.53 | 67.18% |
| 1 Year | 10.81 | 47.97 | 10.42 | 31.59 | 371,115 | 22.86 | 211.47% |
| 3 Years | 10.81 | 47.97 | 10.42 | 31.59 | 371,115 | 22.86 | 211.47% |
| 5 Years | 10.81 | 47.97 | 10.42 | 31.59 | 371,115 | 22.86 | 211.47% |
Spyre Therapeutics Description
| Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. |
